C67.4
Malignant neoplasm of posterior wall of bladder
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the posterior wall of the bladder, classified under ICD-10 code C67.4, refers to a cancerous growth developing on the back portion of the bladder. The bladder is a hollow organ in the pelvis that stores urine until it is expelled from the body. When cancer occurs in this specific area, it can affect the bladder's ability to function normally and may spread to other parts of the body if left untreated. Recognizing the characteristics, causes, and symptoms of this type of bladder cancer is essential for understanding the disease and exploring treatment options.
Causes & Symptoms
Clinical Causes: Tobacco smoking, which significantly increases the risk of bladder cancer Exposure to industrial chemicals such as aromatic amines, often found in certain dyes, rubber, leather, and textile industries Chronic bladder infections or inflammation History of radiation therapy directed at the pelvis Chronic bladder stones or irritants from long-term catheter use Genetic predisposition or family history of bladder cancer Age - most cases occur in older adults, typically over 55 years Gender - males are at higher risk than females
Key Symptoms: Hematuria (blood in urine), which may be visible or detected through tests Frequent urination or the feeling of needing to urinate urgently Pain or a burning sensation during urination Lower back pain on one side (flank pain), especially if the cancer has invaded nearby tissues Pelvic pain in advanced stages Unexplained weight loss or fatigue in later stages
Diagnostic & Treatment
Diagnosis Path: Urinalysis to detect blood, infection, or abnormal cells Urine cytology to identify cancerous cells shed in urine Cystoscopy, a procedure where a thin tube with a camera is inserted into the bladder to visualize the interior and collect tissue samples Biopsy of suspicious tissue for histopathological examination Imaging tests such as computed tomography (CT) scans, magnetic resonance imaging (MRI), or ultrasound to assess the extent and spread of the tumor Additional tests like chest X-rays or bone scans may be performed if metastasis is suspected
Treatment Protocols: Transurethral resection of the bladder tumor (TURBT) — an initial procedure to remove superficial tumors Intravesical therapy — instilling medications directly into the bladder to prevent recurrence or reduce tumor growth Radical cystectomy — surgical removal of the entire bladder and surrounding tissues, often necessary for invasive cancers Chemotherapy — systemic or localized, to target cancer cells and shrink tumors Radiation therapy — used in specific cases, sometimes in combination with surgery or chemotherapy Targeted therapy and immunotherapy — newer treatment modalities that may be suitable for certain types of bladder cancer
Clinical Advice & FAQs
Billing Guidance
Is C67.4 a billable ICD-10 code?
Yes, C67.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C67.4?
Clinical documentation must specify the nature of Malignant neoplasm of posterior wall of bladder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference